Limitations of current therapies to prevent thrombosis: a need for novel strategies
Abstract
Bleeding limits the benefit of current anti-platelet
* Corresponding authors
a
Institut de Génétique et de Biologie Moléculaire et Cellulaire, Institut National de la Santé et de la Recherche Médicale U596, Centre National de la Recherche Scientifique UMR7104, Université Louis Pasteur, 67400 Illkirch, France
E-mail:
jefabre@igbmc.fr
b
deCODE Genetics, Inc., 2501 Davey Road, Woodridge, USA
E-mail:
mgurney@decode.com
Bleeding limits the benefit of current anti-platelet
J. Fabre and M. E. Gurney, Mol. BioSyst., 2010, 6, 305 DOI: 10.1039/B914375K
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content